Novartis | Cafepharma Message Boards | Pharma Sales, Device Sales, …
Apr 17, 2025 · Anonymous board for Novartis. Even in these early responses, it’s clear that AI tools are already part of many people’s day-to-day work.
Novartis scores NFL deal to tackle health outcomes | Cafepharma
Apr 17, 2025 · When Novartis announced it was teaming up with the NFL last month, the company called it the first-ever corporate pharmaceutical partnership with the league. But it wasn’t exactly the …
Novartis | Cafepharma
Jan 27, 2026 · Novartis has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ianalumab, a treatment for Sjögren’s disease, the second most …
September 15 2025 - Novartis dives deeper into protein degraders with ...
Sep 15, 2025 · Novartis dives deeper into protein degraders with second Monte Rosa dealNovartis boardGilead prevails in whistleblower lawsuit over alleged hepatitis C prescription kickbacksGilead …
Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
2 days ago · Competition in obesity drug development remains intense today, as new trial data, combination strategies, and massive investment bets play out alongside earnings updates and policy …
October 27 2025 - Novartis shares slip, Avidity soars after $12 billion ...
Oct 27, 2025 · Novartis shares slip, Avidity soars after $12 billion biotech dealNovartis boardInnovent, Lilly's mazdutide trumps Novo's semaglutide in head-to-head diabetes, weight loss studyEli Lilly …
Federal judge rules Novartis cannot block generic Entresto launch by ...
Jul 16, 2025 · A federal judge in Delaware has ruled that Novartis cannot prevent MSN Pharmaceuticals from introducing a generic version of its heart failure drug, Entresto, in the United States until late …
layoffs | Cafepharma
Jan 8, 2026 · Less than a week after Novartis unveiled a plan to establish a “flagship manufacturing hub” in North Carolina that would add 700 employees to its rolls, the Swiss drugmaker says it is …
Novartis plots 58 layoffs in N.J. amid ongoing efficiency drive ...
Sep 2, 2025 · More than three years after launching a new corporate structure, Novartis is still making changes to its organization. In the latest move to streamline its business, Novartis will lay off 58 …
Novartis dives even deeper into radioligands, notching licensing deal ...
Mar 30, 2021 · Novartis captured attention last week for its Phase III prostate cancer win with a radioligand therapy it picked up for $2 billion back in 2018. Now, Novartis is doubling down on the …